|
T.TH
|
What we don't know is how many may be replacements for some who have left...
|
|
T.TH
|
This is one of our better comp models to think about how Theratech could...
|
|
T.TH
|
I do recall in the papers on sortilin, they also said higher levels were...
|
|
T.TH
|
Interesting stains. I toyed around with this too, getting nowhere. But...
|
|
T.TH
|
"Elands (CEO) highlighted a few reasons why he thinks ETx-22 could...
|
|
T.TH
|
I'll let the real scientist answer the hard questions. But you are...
|
|
T.TH
|
Here’s some Phase 1 results from the drug most see as the nearest direct...
|
|
T.TH
|
I think the thought is that they are not influencing the price at all. ...
|
|
T.TH
|
It appears so, and it's a bit disappointing. The only salve we can take...
|
|
T.TH
|
JPMorgan Healthcare Conf coming up and doesn't appear THTX is bothering...
|
|
T.TH
|
I'm not completely opposed to it for a few reasons, but I can't say...
|
|
T.TH
|
Andre Dupras? New HR guy from Pfizer Canada. Quite generous! I hope these...
|
|
T.TH
|
No need to disparage all the various views presented here. By the way, he...
|
|
T.TH
|
Given all the hiring around operations and sales, I would have hoped to see 2...
|
|
T.TH
|
What's the similarity you see? It doesn't sound very similar...
|
|
T.TH
|
Agree - it won't happen. That's why I have provided this guess for...
|
|
T.TH
|
Yes, we all know this, but quite clearly the there's a large amount of...
|
|
T.TH
|
Paul, throw us a bone if you do know your previous approximate deadline is...
|
|
T.TH
|
I think this is a good review and let's not forget -- if there's POC...
|
|
T.TH
|
Yes, professional production and good PR, even if the THTX guy is talking...
|